| Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic) (NCT04957446) | Sadick Research Group | 2021-08-09 |
| The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment (NCT03836638) | St Joseph University, Beirut, Lebanon | 2019-05-01 |
| PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles (NCT03774849) | Candela Corporation | 2018-12-05 |
| The Use of J-Plasma® for Dermal Resurfacing (NCT03286283) | Apyx Medical | 2018-01-22 |
| Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles (NCT01858415) | Pollogen | 2013-04-01 |
| Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles (NCT02122536) | YMD Eye and Face | 2012-07-01 |
| Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles (NCT01566396) | Pollogen | 2012-03-01 |
| A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines (NCT01447342) | Pacira Pharmaceuticals, Inc | 2011-09-01 |
| Cryo-Touch III Refinement Study Investigational Plan (NCT01379365) | Pacira Pharmaceuticals, Inc | 2011-06-01 |
| Cryo-Touch II for the Treatment of Wrinkles (NCT01167140) | Pacira Pharmaceuticals, Inc | 2010-07-01 |
| Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults (NCT01124565) | Revance Therapeutics, Inc. | 2010-05-01 |
| Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers (NCT01151436) | Galderma R&D | 2010-03-01 |
| Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults (NCT01064518) | Revance Therapeutics, Inc. | 2010-01-01 |
| Retorna Facial Cream in the Treatment of Facial Wrinkles (NCT00978887) | Catalysis SL | 2009-10-01 |
| Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00968942) | Revance Therapeutics, Inc. | 2009-08-01 |
| Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00968825) | Revance Therapeutics, Inc. | 2009-07-01 |
| Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI (NCT00922623) | Merz North America, Inc. | 2009-05-01 |
| Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00888914) | Revance Therapeutics, Inc. | 2008-11-01 |
| Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles (NCT00734786) | Phytotox SA | 2008-08-01 |
| Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft (NCT00877279) | Merz North America, Inc. | 2007-11-01 |
| A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs) (NCT00417469) | Genzyme, a Sanofi Company | 2007-01-01 |
| Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®. (NCT00876265) | Merz North America, Inc. | 2006-12-01 |
| Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds (NCT00407914) | Contura | 2006-12-01 |
| Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds (NCT00414544) | Cosmeta | 2006-10-01 |
| A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique. (NCT00293163) | Genzyme, a Sanofi Company | 2006-02-01 |
| A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast. (NCT00288470) | Genzyme, a Sanofi Company | 2002-06-01 |